- Home
- OCC vs LUNG Comparison
OCC vs LUNG Comparison
Compare OCC & LUNG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OCC
- LUNG
- Stock Information
- Founded
- OCC 1983
- LUNG 1995
- Country
- OCC United States
- LUNG United States
- Employees
- OCC N/A
- LUNG N/A
- Industry
- OCC Telecommunications Equipment
- LUNG Industrial Specialties
- Sector
- OCC Industrials
- LUNG Health Care
- Exchange
- OCC Nasdaq
- LUNG Nasdaq
- Market Cap
- OCC 71.9M
- LUNG 63.6M
- IPO Year
- OCC 1996
- LUNG 2020
- Fundamental
- Price
- OCC $8.01
- LUNG $1.97
- Analyst Decision
- OCC
- LUNG Buy
- Analyst Count
- OCC 0
- LUNG 7
- Target Price
- OCC N/A
- LUNG $6.81
- AVG Volume (30 Days)
- OCC 72.1K
- LUNG 6.7M
- Earning Date
- OCC 12-22-2025
- LUNG 11-12-2025
- Dividend Yield
- OCC N/A
- LUNG N/A
- EPS Growth
- OCC N/A
- LUNG N/A
- EPS
- OCC N/A
- LUNG N/A
- Revenue
- OCC $72,694,849.00
- LUNG $90,549,000.00
- Revenue This Year
- OCC N/A
- LUNG $10.41
- Revenue Next Year
- OCC N/A
- LUNG $10.98
- P/E Ratio
- OCC N/A
- LUNG N/A
- Revenue Growth
- OCC 12.67
- LUNG 18.24
- 52 Week Low
- OCC $2.02
- LUNG $1.47
- 52 Week High
- OCC $11.50
- LUNG $9.37
- Technical
- Relative Strength Index (RSI)
- OCC 48.42
- LUNG 56.36
- Support Level
- OCC $7.10
- LUNG $1.65
- Resistance Level
- OCC $8.26
- LUNG $2.11
- Average True Range (ATR)
- OCC 0.72
- LUNG 0.23
- MACD
- OCC -0.03
- LUNG 0.03
- Stochastic Oscillator
- OCC 35.31
- LUNG 30.56
About OCC Optical Cable Corporation
Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.
About LUNG Pulmonx Corporation
Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.